Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity

DSpace/Manakin Repository

Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity

Citable link to this page

 

 
Title: Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity
Author: Werz, Oliver; Gerstmeier, Jana; Libreros, Stephania; De la Rosa, Xavier; Werner, Markus; Norris, Paul C.; Chiang, Nan; Serhan, Charles N.

Note: Order does not necessarily reflect citation order of authors.

Citation: Werz, Oliver, Jana Gerstmeier, Stephania Libreros, Xavier De la Rosa, Markus Werner, Paul C. Norris, Nan Chiang, and Charles N. Serhan. 2018. “Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity.” Nature Communications 9 (1): 59. doi:10.1038/s41467-017-02538-5. http://dx.doi.org/10.1038/s41467-017-02538-5.
Full Text & Related Files:
Abstract: Proinflammatory eicosanoids (prostaglandins and leukotrienes) and specialized pro-resolving mediators (SPM) are temporally regulated during infections. Here we show that human macrophage phenotypes biosynthesize unique lipid mediator signatures when exposed to pathogenic bacteria. E. coli and S. aureus each stimulate predominantly proinflammatory 5-lipoxygenase (LOX) and cyclooxygenase pathways (i.e., leukotriene B4 and prostaglandin E2) in M1 macrophages. These pathogens stimulate M2 macrophages to produce SPMs including resolvin D2 (RvD2), RvD5, and maresin-1. E. coli activates M2 macrophages to translocate 5-LOX and 15-LOX-1 to different subcellular locales in a Ca2+-dependent manner. Neither attenuated nor non-pathogenic E. coli mobilize Ca2+ or activate LOXs, rather these bacteria stimulate prostaglandin production. RvD5 is more potent than leukotriene B4 at enhancing macrophage phagocytosis. These results indicate that M1 and M2 macrophages respond to pathogenic bacteria differently, producing either leukotrienes or resolvins that further distinguish inflammatory or pro-resolving phenotypes.
Published Version: doi:10.1038/s41467-017-02538-5
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754355/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34868864
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters